Kane Biotech Inc Ord (KNBIF) Q1 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Kane Biotech Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:02.050 Good afternoon, and thank you for standing by. 00:00:02.050 -- 00:00:05.872 Welcome to Cain Biotech's first quarter 2023 00:00:05.872 -- 00:00:10.675 earnings conference call. During today's presentation, all parties will be in a listen-only 00:00:10.675 -- 00:00:15.457 mode. Following the presentation, the conference call will be open to questions. 00:00:15.457 -- 00:00:19.920 If you have a question, simply press star 1-1 on your telephone. 00:00:19.920 -- 00:00:24.642 If you would like to withdraw your question, simply press star 1-1 again. 00:00:24.642 -- 00:00:28.894 This conference is being recorded today, May 25, 2023. 00:00:29.975 -- 00:00:35.118 I would now like to turn the conference call over to Nicole Cain Biotech's investor 00:00:35.118 -- 00:00:38.759 relations advisor. Please go ahead. 00:00:38.961 -- 00:00:43.444 Thank you, operator. Good afternoon and welcome everyone to Cain Biotech's quarterly 00:00:43.444 -- 00:00:47.166 earnings conference call. We are delighted to have you join us today. 00:00:47.166 -- 00:00:52.649 This call will cover Cain's financial and operating results for the first quarter 00:00:52.649 -- 00:00:54.659 of 2023 00:00:54.971 -- 00:01:00.221 along with a discussion of some of our recent highlights and goals for 2023 00:01:00.221 -- 00:01:04.702 and beyond. Following our prepared remarks, we will open the conference call to a question 00:01:04.702 -- 00:01:10.084 and answer period. Our call today will be led by Cane's Chief Executive Officer, 00:01:10.084 -- 00:01:14.886 Mark Edwards. Before we begin our formal remarks, I would like to remind everyone that 00:01:14.886 -- 00:01:19.528 some of the statements on this conference call contain certain forward-looking information 00:01:19.528 -- 00...